24 Sep 2012, BioSpectrum Bureau , BioSpectrum
Bangalore: Dr. Reddy's Laboratories launched Amoxicillin tablets, capsules, and oral suspension, a bioequivalent generic version of Amoxil (Amoxicillin) tablets, capsules, and oral suspension in the US. Amoxicillin tablets (500 mg and 875 mg), capsules (250 mg and 500 mg), and oral suspension (125 mg/5 ml, 200 mg/5 ml, 250 mg/5 ml, and 400 mg/5 ml) are approved by the US FDA.
The Amoxil brand and generic tablets (875 mg) has US sales of approximately $22.2 Million, capsules have US sales of approximately $67.2 million, and oral suspension has US sales of approximately $89.5 Million, all for the most recent 12 months ending June 2012 according to IMS Health.
Dr. Reddy's Amoxicillin tablets in 500 mg and 875 mg are available in bottle counts of 20 and 100. Amoxicillin capsules in 250 mg and 500 mg are available in bottle counts of 100 and 500. Amoxicillin oral suspension in 200 mg/5 ml and 400 mg/5 ml are available in bottle sizes of 50 ml, 75 ml, and 100 ml. Amoxicillin oral suspension in 125 mg/5 ml and 250 mg/5 ml are available in bottle sizes of 80 ml, 100 ml, and 150 ml.